CHRYSOS CORP. LIMITED (C79)
Share Price Analysis and Chart

05/05/2026

1

Buy

$9.00

31.77%

Chrysos served up a May trading update with Bell Potter highlighting it has retained its robust lease win momentum since the 1H26 results with five additional agreements.

Contracted units for FY26 are 19 with a backlog of 34, up from 30 at the half year, while new lease agreements with ALS Ltd ((ALQ)) have also been secured.

The analyst believes this is a positive sign for industry use of photoassay technology.

Management reconfirmed FY26 guidance with revenue tracking at the upper end of the $80m-$90m range. The analyst notes 2H26 deployment are some -2 to -3 units below forecast of 7.

EPS forecasts are tweaked lower for FY26/FY27. Target price slips to $9 from $9.40, Buy rating retained.

FORECAST
Bell Potter forecasts a full year FY26 dividend of 0.00 cents and EPS of 2.10 cents.
Bell Potter forecasts a full year FY27 dividend of 0.00 cents and EPS of 6.00 cents.

11/05/2026

1

Buy

$8.80

28.84%

Shaw and Partners reiterates a Buy rating and increases the price target for Chrysos to $8.80 following a confident update at the TechRise Conference in Sydney.

Management reiterated FY26 guidance at the top end despite -10% foreign exchange headwinds, with contracting momentum accelerating to 19 units year-to-date.

Improving visibility suggests an 18-unit deployment cadence in FY27, supported by gross margins of 70-80% per unit and structural fire assay cost inflation.

The broker feels the strategic framing of AI as an operational decision layer enhances long-term value beyond simple fire assay replacement.

The price target shift to $8.80 from $8.70 reflects strong unit economics and continued sample volume growth exceeding 60% year-on-year.

FORECAST
Shaw and Partners forecasts a full year FY26 dividend of 0.00 cents and EPS of 6.00 cents.
Shaw and Partners forecasts a full year FY27 dividend of 0.00 cents and EPS of 12.50 cents.